Breathing better through bugs: Asthma and the microbiome

Yale Journal of Biology and Medicine

Volumn 89, Issue 3, 2016, Pages 309-324

  Adami, Alexander J ^a   Bracken, Sonali J ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Allergy; Asthma; Hygiene hypothesis; Immune system; Immunity; Microbiome; Microbiota

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN E; INTERLEUKIN 4; MACROLIDE; PREBIOTIC AGENT; PROBIOTIC AGENT;

ALLERGEN SPECIFIC IMMUNOTHERAPY; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANTIBIOTIC RESISTANCE; ASTHMA; B LYMPHOCYTE; CHEST TIGHTNESS; CYTOKINE PRODUCTION; DENDRITIC CELL; DIETARY FIBER; DYSPNEA; ENVIRONMENTAL EXPOSURE; EOSINOPHILIA; EPIDEMIC; HAEMOPHILUS INFLUENZAE; HUMAN; HYGIENE HYPOTHESIS; IMMUNOREGULATION; IMMUNOTHERAPY; LACTOBACILLUS; MICROBIOME; MUCUS SECRETION; NEUTROPHILIA; NONHUMAN; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFLAMMATION; REVIEW; TH17 CELL; TH2 CELL; WHEEZING; ANIMAL; HYPERSENSITIVITY; MICROBIOLOGY; MICROFLORA; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ASTHMA; HUMANS; HYPERSENSITIVITY; MICROBIOTA;

EID: 84989282528     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (203)

1. Postma DS, Rabe KF. The Asthma-COPD Overlap Syndrome. N Engl J. Med. 2015;373(13):1241–1249.
2. Berair R, Saunders R, Brightling CE. Origins of increased airway smooth muscle mass in asthma. BMC Med. 2013;11:145.
3. Fanta CH. Asthma. N Engl J Med. 2009;360(10):1002–1014.
4. Bisgaard H, Bønnelykke K. Long-term studies of the natural history of asthma in childhood. J Allergy Clin Immunol. 2010;126(2):187-197-199.
5. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716–725.
6. Sears MR. Trends in the prevalence of asthma. Chest. 2014;145(2):219–225.
7. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45–56.
8. Lötvall J et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127(2):355–360.
9. Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 cells: new players in asthma pathogenesis. Allergy. 2011;66(8):989–998.
10. Liang SC et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol. 2007;179(11):7791–7799.
11. McKinley L et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol. 2008;181(6):4089–4097.
12. Kudo M et al. IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat Med. 2012;18(4):547–554.
13. Shaw DE et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest. 2007;132(6):1871–1875.
14. Barczyk A et al. Decreased percentage of CD4(+) Foxp3(+) TGF-β(+) and increased percentage of CD4(+)IL-17(+) cells in bronchoalveolar lavage of asthmatics. J Inflamm Lond Engl. 2014;11:22.
15. Ramesh R et al. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med. 2014;211(1):89–104.
16. Chesné J et al. IL-17 in severe asthma. Where do we stand? Am J Respir Crit Care Med. 2014;190(10):1094–1101.
17. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996;184(2):387–396.
18. Ray A, Khare A, Krishnamoorthy N, Qi Z, Ray P. Regulatory T cells in many flavors control asthma. Mucosal Immunol. 2010;3(3):216–229.
19. Ostroukhova M et al. Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J Clin Invest. 2004;114(1):28–38.
20. Whitehead GS et al. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol. 2012;129(1):207–215.
21. Akkoc T, Akdis M, Akdis CA. Update in the mechanisms of allergen-specific immunotheraphy. Allergy Asthma Immunol Res. 2011;3(1):11–20.
22. Carson WF IV et al. Accumulation of regulatory T cells in local draining lymph nodes of the lung correlates with spontaneous resolution of chronic asthma in a murine model. Int Arch Allergy Immunol. 2008;145(3):231–243.
23. Bracken SJ et al. Long-Term Exposure to House Dust Mite Leads to the Suppression of Allergic Airway Disease Despite Persistent Lung Inflammation. Int Arch Allergy Immunol. 2015;166(4):243–258.
24. Mamessier E et al. T-cell activation during exacerbations: a longitudinal study in refractory asthma. Allergy. 2008;63(9):1202–1210.
25. Akdis M et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004;199(11):1567–1575.
26. Robinson DS. Regulatory T cells and asthma. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2009;39(9):1314– 1323.
27. Lin Y-L, Shieh C-C, Wang J-Y. The functional insufficiency of human CD4+CD25 high T-regulatory cells in allergic asthma is subjected to TNF-alpha modulation. Allergy. 2008;63(1):67–74.
28. Hartl D et al. Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol. 2007;119(5):1258–1266.
29. Schröder PC et al. IL-33 polymorphisms are associated with increased risk of hay fever and reduced Regulatory T cells in a birth cohort. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2016.
30. Smyth LJC, Eustace A, Kolsum U, Blaikely J, Singh D. Increased airway T regulatory cells in asthmatic subjects. Chest. 2010;138(4):905–912.
31. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221–241.
32. Singh A et al. Regulatory Role of B Cells in a Murine Model of Allergic Airway Disease. J Immunol. 2008;180(11):7318– 7326.
33. Amu S et al. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol. 2010;125(5):1114–1124.e8.
34. Natarajan P et al. Regulatory B cells from hilar lymph nodes of tolerant mice in a murine model of allergic airway disease are CD5(+), express TGF-β, and co-localize with CD4(+)Foxp3(+) T cells. Mucosal Immunol. 2012;5(6):691-701.
35. van der Vlugt LEPM et al. CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2014;44(4):517–528.
36. Fujita S et al. Regulatory dendritic cells protect against allergic airway inflammation in a murine asthmatic model. J Allergy Clin Immunol. 2008;121(1):95–104.e7.
37. Huang H, Dawicki W, Zhang X, Town J, Gordon JR. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells. J Immunol. 2010;185(9):5003–5010.
38. Secor ER et al. Bromelain Inhibits Allergic Sensitization and Murine Asthma via Modulation of Dendritic Cells. Evid-Based Complement Altern Med. ECAM 2013;2013:702196.
39. Bernatchez E et al. Pulmonary CD103 expression regulates airway inflammation in asthma. Am J Physiol Lung Cell Mol Physiol. 2015;308(8):L816-826.
40. Plantinga M et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity. 2013;38(2):322–335.
41. Lewkowich IP et al. CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med. 2005;202(11):1549–1561.
42. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355(21):2226–2235.
43. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980-2007. Pediatrics. 2009;123 Suppl 3:S131-145.
44. Akinbami LJ, Moorman JE, Liu X. Asthma prevalence, health care use, and mortality: United States, 2005-2009. Natl Health Stat Rep. 2011;(32):1–14.
45. Moorman JE et al. National surveillance of asthma: United States, 2001-2010. Vital Health Stat. Ser. 3 Anal. Epidemiol. Stud. US Dept Health Hum. Serv. Public Health Serv. Natl. Cent. Health Stat. 2012;(35):1–58.
46. Akinbami LJ, Simon AE, Rossen LM. Changing Trends in Asthma Prevalence Among Children. Pediatrics 2016;137(1):1–7.
47. National Center for Health Statistics. Health, United States, 2014: With Special Feature on Adults Aged 55–64 [Internet]. Hyattsville, MD: Centers for Disease Control; 2015. Available from: http://www.cdc.gov/nchs/hus.htm
48. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259–1260.
49. Strachan DP. Family size, infection and atopy: the first decade of the “hygiene hypothesis.” Thorax. 2000;55 Suppl 1:S2-10.
50. Gerrard JW, Geddes CA, Reggin PL, Gerrard CD, Horne S. Serum IgE levels in white and metis communities in Saskatchewan. Ann Allergy 1976;37(2):91–100.
51. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol. 2001;1(1):69–75.
52. Lederberg J, McCray A. ’Ome Sweet ’Omics—a genealogical treasury of words. The Scientist. 2001;15(7):8.
53. Huss J. Methodology and Ontology in Microbiome Research. Biol Theory. 2014;9(4):392–400.
54. Burge MN. Fungi in Biological Control Systems. Manchester University Press; 1988.
55. Mohr JL. Protozoa as Indicators of Pollution. Sci. Mon. 1952;74(1):7–9.
56. Revue odontologique. Société syndicate odontologique de France; 1949.
57. Leeuwenhoek A van. Ontledingen en ontdekkingen van levende dierkens in de teel-deelen van verscheide dieren, vogelen en visschen: van het hout met der solver meenigvuldige vaaton … Leiden: C. Boutesteyn; 1686.
58. Dobell C, Leeuwenhoek A van. Antony van Leeuwenhoek and his “Little animals”; being some account of the father of protozoology and bacteriology and his multifarious discoveries in these disciplines; [Internet]. New York, Harcourt, Brace and company; 1932.[cited 2016 May 21 ] Available from: http://archive.org/details/antonyvanleeuwen00dobe
59. Metchnikoff E. The Prolongation of Life: Optimistic Studies. [Internet]. New York & London: G.P. Putnam’s Sons; 1908.[cited 2015 Jan 17 ] Available from: http://archive.org/details/prolongationofli00metciala
60. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7(12):887–894.
61. Rook GA et al. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immunopathol. 2004;25(3-4):237–255.
62. von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol. 2010;10(12):861– 868.
63. Von Ehrenstein OS et al. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2000;30(2):187–193.
64. Riedler J, Eder W, Oberfeld G, Schreuer M. Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2000;30(2):194–200.
65. Braun-Fahrländer C et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med. 2002;347(12):869–877.
66. Sordillo JE et al. Multiple microbial exposures in the home may protect against asthma or allergy in childhood. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2010;40(6):902– 910.
67. Illi S et al. Protection from childhood asthma and allergy in Alpine farm environments-the GABRIEL Advanced Studies. J Allergy Clin Immunol. 2012;129(6):1470–1477.e6.
68. Feng M et al. Associations of early life exposures and environmental factors with asthma among children in rural and urban areas of Guangdong, China. Chest. 2016;149(4):1030– 1041.
69. Riedler J et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet Lond Engl. 2001;358(9288):1129–1133.
70. Ege MJ et al. Not all farming environments protect against the development of asthma and wheeze in children. J Allergy Clin Immunol. 2007;119(5):1140–1147.
71. Karvonen AM et al. Exposure to microbial agents in house dust and wheezing, atopic dermatitis and atopic sensitization in early childhood: a birth cohort study in rural areas. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2012;42(8):1246–1256.
72. Karvonen AM et al. Quantity and diversity of environmental microbial exposure and development of asthma: a birth cohort study. Allergy. 2014;69(8):1092–1101.
73. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med. 2007;167(8):821–827.
74. Penders J et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut. 2007;56(5):661–667.
75. Ege MJ et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011;364(8):701–709.
76. Bisgaard H et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 2011;128(3):646-652–5.
77. Lynch SV et al. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J Allergy Clin Immunol. 2014;134(3):593–601.e12.
78. Abrahamsson TR et al. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2014;44(6):842–850.
79. Dannemiller KC et al. Next-generation DNA sequencing reveals that low fungal diversity in house dust is associated with childhood asthma development. Indoor Air. 2014;24(3):236–247.
80. Arrieta M-C et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7(307):307ra152.
81. Ciaccio CE et al. Home dust microbiota is disordered in homes of low-income asthmatic children. J Asthma Off J Assoc Care Asthma. 2015;52(9):873–880.
82. Dannemiller KC, Gent JF, Leaderer BP, Peccia J. Indoor microbial communities: Influence on asthma severity in atopic and nonatopic children. J Allergy Clin Immunol. 2016;138(1):76-83.
83. van Nimwegen FA et al. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol. 2011;128(5):948-955–3.
84. Vael C, Vanheirstraeten L, Desager KN, Goossens H. Denaturing gradient gel electrophoresis of neonatal intestinal microbiota in relation to the development of asthma. BMC Microbiol. 2011;11:68.
85. Nathan C, Cars O. Antibiotic Resistance — Problems, Progress, and Prospects. N Engl J Med. 2014;371(19):1761– 1763.
86. Koenig JE et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA. 2011;108 Suppl 1:4578–4585.
87. Schulfer A, Blaser MJ. Risks of Antibiotic Exposures Early in Life on the Developing Microbiome. PLoS Pathog. 2015;11(7):e1004903.
88. Capone KA, Dowd SE, Stamatas GN, Nikolovski J. Diversity of the Human Skin Microbiome Early in Life. J Invest Dermatol. 2011;131(10):2026–2032.
89. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA. 2011;108 Suppl 1:4554–4561.
90. Keeney KM, Yurist-Doutsch S, Arrieta M-C, Finlay BB. Effects of antibiotics on human microbiota and subsequent disease. Annu Rev Microbiol. 2014;68:217–235.
91. Droste JH et al. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2000;30(11):1547–1553.
92. Sobko T et al. Neonatal sepsis, antibiotic therapy and later risk of asthma and allergy. Paediatr Perinat Epidemiol. 2010;24(1):88–92.
93. Mai X-M, Kull I, Wickman M, Bergström A. Antibiotic use in early life and development of allergic diseases: respiratory infection as the explanation. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2010;40(8):1230–1237.
94. Kwon J-W et al. Changes in the Prevalence of Childhood Asthma in Seoul from 1995 to 2008 and Its Risk Factors. Allergy Asthma Immunol Res. 2011;3(1):27–33.
95. Risnes KR, Belanger K, Murk W, Bracken MB. Antibiotic exposure by 6 months and asthma and allergy at 6 years: Findings in a cohort of 1,401 US children. Am J Epidemiol. 2011;173(3):310–318.
96. Murk W, Risnes KR, Bracken MB. Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review. Pediatrics. 2011;127(6):1125–1138.
97. Lapin B et al. The Relationship of Early-Life Antibiotic Use with Asthma in At-Risk Children. J Allergy Clin Immunol. 2014;134(3):728–729.
98. Örtqvist AK et al. Antibiotics in fetal and early life and subsequent childhood asthma: nationwide population based study with sibling analysis. BMJ. 2014;349:g6979.
99. Noverr MC, Noggle RM, Toews GB, Huffnagle GB. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun. 2004;72(9):4996–5003.
100. Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun. 2005;73(1):30–38.
101. Russell SL et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012;13(5):440–447.
102. Hill DA et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med. 2012;18(4):538–546.
103. Russell SL et al. Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes. 2013;4(2):158–164.
104. Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol. 2012;30:759– 795.
105. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268–1273.
106. Belkaid Y, Hand TW. Role of the Microbiota in Immunity and Inflammation. Cell. 2014;157(1):121–141.
107. Samuelson DR, Welsh DA, Shellito JE. Regulation of lung immunity and host defense by the intestinal microbiota. Front Microbiol. 2015;6:1085.
108. Palm NW, de Zoete MR, Flavell RA. Immune-microbiota interactions in health and disease. Clin Immunol. 2015;159(2):122–127.
109. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453(7195):620–625.
110. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA. 2010;107(27):12204– 12209.
111. Round JL et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011;332(6032):974–977.
112. Atarashi K et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331(6015):337–341.
113. Furusawa Y et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446–450.
114. Arpaia N et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451–455.
115. Smith PM et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341(6145):569–573.
116. Atarashi K et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500(7461):232–236.
117. Maslowski KM et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461(7268):1282–1286.
118. Trompette A et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20(2):159–166.
119. Thorburn AN et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun. 2015;6:7320.
120. O’Mahony C et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog. 2008;4(8):e1000112.
121. Arnold IC et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest. 2011;121(8):3088–3093.
122. Oertli M et al. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest. 2012;122(3):1082– 1096.
123. Engler DB et al. Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. Proc Natl Acad Sci USA. 2014;111(32):11810–11815.
124. Fujimura KE et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci USA. 2014;111(2):805–810.
125. Tsukahara T, Hashizume K, Koyama H, Ushida K. Stimulation of butyrate production through the metabolic interaction among lactic acid bacteria, Lactobacillus acidophilus, and lactic acid-utilizing bacteria, Megasphaera elsdenii, in porcine cecal digesta. Anim Sci J. 2006;77(4):454–461.
126. Reynolds LA, Finlay BB. Worming Their Way into the Picture: Microbiota Help Helminths Modulate Host Immunity. Immunity. 2015;43(5):840–842.
127. Wilson MS et al. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med. 2005;202(9):1199–1212.
128. Kitagaki K et al. Intestinal helminths protect in a murine model of asthma. J Immunol. 2006;177(3):1628–1635.
129. Grainger JR et al. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J Exp Med. 2010;207(11):2331–2341.
130. Reynolds LA et al. Commensal-pathogen interactions in the intestinal tract: lactobacilli promote infection with, and are promoted by, helminth parasites. Gut Microbes. 2014;5(4):522–532.
131. Zaiss MM et al. The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation. Immunity. 2015;43(5):998–1010.
132. van der Vlugt LEPM et al. Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PloS One. 2012;7(2):e30883.
133. Blankenhaus B et al. Strongyloides ratti infection induces expansion of Foxp3+ regulatory T cells that interfere with immune response and parasite clearance in BALB/c mice. J Immunol. 2011;186(7):4295–4305.
134. Smits HH et al. Selective probiotic bacteria induce IL-10producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol. 2005;115(6):1260–1267.
135. Ball TM et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med. 2000;343(8):538–543.
136. Sudo N et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997;159(4):1739–1745.
137. Herbst T et al. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med. 2011;184(2):198–205.
138. Ivanov II et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4(4):337–349.
139. Ivanov II et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485–498.
140. Wood LG, Simpson JL, Hansbro PM, Gibson PG. Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia. Free Radic Res. 2010;44(2):146– 154.
141. Essilfie A-T et al. Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog. 2011;7(10):e1002244.
142. McCann JR, Mason SN, Auten RL, Geme JWS, Seed PC. Early life intranasal colonization with nontypeable Haemophilus influenzae exacerbates juvenile airways disease in mice. Infect Immun. 2016;84(7):2022-30.
143. Zhang B, An J, Shimada T, Liu S, Maeyama K. Oral administration of Enterococcus faecalis FK-23 suppresses Th17 cell development and attenuates allergic airway responses in mice. Int J Mol Med. 2012;30(2):248–254.
144. Palanivel V et al. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol. 1996;84(2):168–177.
145. Correale J, Farez M, Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol. 2008;64(2):187–199.
146. Sayi A et al. TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J Immunol. 2011;186(2):878–890.
147. Neves P et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity. 2010;33(5):777–790.
148. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med. 1969;281(21):1137– 1140.
149. Higuchi JH, Coalson JJ, Johanson WG. Bacteriologic diagnosis of nosocomial pneumonia in primates. Usefulness of the protected specimen brush. Am Rev Respir Dis. 1982;125(1):53–57.
150. Baughman RP, Thorpe JE, Staneck J, Rashkin M, Frame PT. Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes. Chest. 1987;91(2):233– 236.
151. Thorpe JE, Baughman RP, Frame PT, Wesseler TA, Staneck JL. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis. 1987;155(5):855–861.
152. Chastre J et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med. 1988;85(4):499–506.
153. Peterson J et al. The NIH Human Microbiome Project. Genome Res. 2009;19(12):2317–2323.
154. Segal LN, Blaser MJ. A Brave New World: The Lung Microbiota in an Era of Change. Ann Am Thorac Soc. 2014;11(Suppl 1):S21–S27.
155. Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The Microbiome and the Respiratory Tract. Annu Rev Physiol. 2016;78:481–504.
156. Hilty M et al. Disordered microbial communities in asthmatic airways. PloS One. 2010;5(1):e8578.
157. Huang YJ et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol. 2011;127(2):372-381–3.
158. Goleva E et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med. 2013;188(10):1193–1201.
159. Huang YJ et al. The airway microbiome in patients with severe asthma: Associations with disease features and severity. J Allergy Clin Immunol. 2015;136(4):874–884.
160. Zhang Q et al. Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes. PloS One. 2016;11(4):e0152724.
161. Bisgaard H et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007;357(15):1487–1495.
162. Teo SM et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015;17(5):704– 715.
163. Gollwitzer ES et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med. 2014;20(6):642– 647.
164. Schuijs MJ et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science. 2015;349(6252):1106–1110.
165. Shim J-U et al. Flagellin suppresses experimental asthma by generating regulatory dendritic cells and T cells. J Allergy Clin Immunol. 2016;137(2):426–435.
166. Hart TK et al. Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin Exp Immunol. 2002;130(1):93–100.
167. Leckie MJ et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet Lond Engl. 2000;356(9248):2144–2148.
168. Flood-Page P et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med. 2007;176(11):1062–1071.
169. Gauvreau GM et al. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med. 2011;183(8):1007–1014.
170. Kanoh S, Rubin BK. Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications. Clin Microbiol Rev. 2010;23(3):590–615.
171. Wong EHC, Porter JD, Edwards MR, Johnston SL. The role of macrolides in asthma: current evidence and future directions. Lancet Respir Med. 2014;2(8):657–670.
172. Kew KM, Undela K, Kotortsi I, Ferrara G. Macrolides for chronic asthma. Cochrane Database Syst Rev. 2015;9:CD002997.
173. Noon L. Originally published as Volume 1, Issue 4580 PROPHYLACTIC INOCULATION AGAINST HAY FEVER. The Lancet. 1911;177(4580):1572–1573.
174. Barnes PJ. New therapies for asthma: is there any progress? Trends Pharmacol Sci. 2010;31(7):335–343.
175. Durham SR et al. Long-term clinical efficacy of grasspollen immunotherapy. N Engl J Med. 1999;341(7):468– 475.
176. Eng PA, Reinhold M, Gnehm HPE. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy. 2002;57(4):306–312.
177. Ali I, Goksal K, Ozan B, Gulsen D. Long-term allergen-specific immunotherapy correlates with long-term allergen-specific immunological tolerance. Adv Ther. 2008;25(1):29–36.
178. Hankin CS, Cox L, Bronstone A, Wang Z. Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis. J Allergy Clin Immunol. 2013;131(4):1084–1091.
179. Greenberg MA et al. Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy. J Allergy Clin Immunol. 1986;77(6):865–870.
180. Roy SR et al. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2007;99(1):82–86.
181. Cox L. Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2006;97(2):126-137-140, 202.
182. Mellerup MT, Hahn GW, Poulsen LK, Malling H. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2000;30(10):1423–1429.
183. Caminati M et al. Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety. Expert Rev Clin Immunol. 2015;11(2):233–245.
184. Huggins JL, Looney RJ. Allergen immunotherapy. Am Fam Physician. 2004;70(4):689–696.
185. Cox L et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1-55.
186. Sanders ME. Probiotics: definition, sources, selection, and uses. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;46 Suppl 2:S58-61-151.
187. Forsythe P, Inman MD, Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med. 2007;175(6):561–569.
188. Ezendam J, van Loveren H. Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice. Br J Nutr. 2008;99(1):83–90.
189. Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med. 2009;179(3):186–193.
190. Harb H et al. Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2013;43(3):353– 364.
191. Jang S-O et al. Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4(+)CD25(+)Foxp3(+) T Cells. Allergy Asthma Immunol Res. 2012;4(3):150–156.
192. MacSharry J et al. Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse. Pulm Pharmaco. Ther. 2012;25(4):325–334.
193. Elazab N et al. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics. 2013;132(3):e666-676.
194. Bakken JS et al. Treating Clostridium difficile Infection with Fecal Microbiota Transplantation. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2011;9(12):1044–1049.
195. Brandt LJ et al. Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection. Am J Gastroenterol. 2012;107(7):1079– 1087.
196. Youngster I et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312(17):1772–1778.
197. Martinez FD, Firmage L. Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX) [Internet]. In: ClinicalTrials.gov. Bethesda, MD: National Library of Medicine; 2000. Available from: https://clinicaltrials.gov/ct2/show/NCT02148796.
198. Hadebe S et al. Microbial Ligand Costimulation Drives Neutrophilic Steroid-Refractory Asthma. PloS One. 2015;10(8):e0134219.
199. Slavin J. Fiber and Prebiotics: Mechanisms and Health Benefits. Nutrients. 2013;5(4):1417–1435.
200. Ludwig D, Hron B, Ebbeling C. Asthma (and Dietary) Inflammation Reduction (AIR). ClinicalTrials.gov [date unknown]
201. Arslanoglu S et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008;138(6):1091–1095.
202. Arslanoglu S et al. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic man- ifestations in the first 5 years of life. J Biol Regul Homeost Agents. 2012;26(3 Suppl):49–59.
203. Kukkonen AK et al. Airway inflammation in probiotic-treated children at 5 years. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2011;22(2):249–251.